Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Properties of Acyclovir
NCT04988646Completed
- Sponsor
- Kimia Farma
- Start
- Feb 2020
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of aciclovir in herpes simplex (HSV) and varicella zoster virus infection (2 arms), sponsored by Kimia Farma. Primary endpoint: Pharmacokinetics Parameter at 24 hours. Started Feb 2020; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes simplex (HSV)varicella zoster virus infection
Beyond the preview
Go deeper on NCT04988646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04988646.